AURA
Aura Biosciences, Inc.Company with tickers: AURA
CIK
1501796
CUSIP
05153U107
Shares Outstanding
103,386,558
13F Activity (30d)
86 filings
84 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2021-10-28 | Mariggi Giovanni |
Director | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | De Rosch Mark |
Chief Operating Officer | Award | 17,500 |
| 2021-10-28 | Medicxi Ventures Management (Jersey) Ltd |
10% Owner | Other | 0 |
| 2021-10-28 | Primiano Christopher Brett |
Chief Business Officer | Other | 0 |
| 2021-10-28 | Feder Julie B |
Chief Financial Officer | Award | 112,500 |
| 2021-10-28 | Srivastava Sapna |
Director | Award | 16,000 |
| 2021-10-28 | Rich Cadmus |
See Remarks | Other | 0 |
| 2021-10-28 | PAREKH RAJESH B |
Director | Award | 16,000 |
| 2021-10-28 | Mattessich Antony C. |
Director, President and CEO | Award | 16,000 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Award | 318,750 |
| 2021-10-28 | Mattessich Antony C. |
Director, President and CEO | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | Primiano Christopher Brett |
Chief Business Officer | Award | 37,500 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Award | 74,357 |
| 2021-10-28 | Johnson David Michael |
Director | Award | 24,000 |
| 2021-10-28 | Johnson David Michael |
Director | Other | 0 |
| 2021-10-28 | Rich Cadmus |
See Remarks | Award | 26,250 |
| 2021-10-28 | PAREKH RAJESH B |
Director | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | Medicxi Ventures Management (Jersey) Ltd |
10% Owner | Other | 0 |
| 2021-10-28 | Medicxi Ventures Management (Jersey) Ltd |
10% Owner | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | Primiano Christopher Brett |
Chief Business Officer | Award | 8,750 |
| 2021-10-28 | Johnson David Michael |
Director | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | Rich Cadmus |
See Remarks | Other | 0 |
| 2021-10-28 | Medicxi Ventures Management (Jersey) Ltd |
10% Owner | Other | 0 |
| 2021-10-28 | Feder Julie B |
Chief Financial Officer | Other | 0 |
| 2021-10-28 | Feder Julie B |
Chief Financial Officer | Other | 0 |
| 2021-10-28 | Feder Julie B |
Chief Financial Officer | Other | 0 |
| 2021-10-28 | Feder Julie B |
Chief Financial Officer | Other | 0 |
| 2021-10-28 | Rich Cadmus |
See Remarks | Award | 112,500 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 126,860 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | De Rosch Mark |
Chief Operating Officer | Award | 75,000 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | Feder Julie B |
Chief Financial Officer | Award | 26,250 |
| 2021-10-28 | Rich Cadmus |
See Remarks | Other | 0 |
| 2021-10-28 | Rich Cadmus |
See Remarks | Other | 0 |
| 2021-10-28 | Medicxi Ventures Management (Jersey) Ltd |
10% Owner | Other | 0 |
| 2021-10-28 | De Rosch Mark |
Chief Operating Officer | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 126,860 |
| 2021-10-28 | Medicxi Ventures Management (Jersey) Ltd |
10% Owner | Other | 0 |
| 2021-10-28 | Srivastava Sapna |
Director | Other | 0 |
| 2021-10-28 | Matrix Capital Management Company, LP |
10% Owner | Other | 0 |
| 2021-10-28 | Johnson David Michael |
Director | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
| 2021-10-28 | de los Pinos Elisabet |
Director, See Remarks | Other | 0 |
Showing 1–50 of 293 transactions